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Abstract
Objective
African Americans, East Asians, and Hispanics with systemic lupus erythematous (SLE) are
more likely to develop lupus nephritis (LN) than are SLE patients of European descent. The
etiology of this difference is not clear, and this study was undertaken to investigate how
genetic variants might explain this effect.
Methods
In this cross-sectional study, 1244 SLE patients from multiethnic case collections were gen-
otyped for 817,810 single-nucleotide polymorphisms (SNPs) across the genome. Continen-
tal genetic ancestry was estimated utilizing the program ADMIXTURE. Gene-based testing
and pathway analysis was performed within each ethnic group and meta-analyzed across
ethnicities. We also performed candidate SNP association tests with SNPs previously
established as risk alleles for SLE, LN, and chronic kidney disease (CKD). Association test-
ing and logistic regression models were performed with LN as the outcome, adjusted for
continental ancestries, sex, disease duration, and age.
Results
We studied 255 North European, 263 South European, 238 Hispanic, 224 African American
and 264 East Asian SLE patients, of whom 606 had LN (48.7%). In genome-wide gene-
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based and candidate SNP analyses, we found distinct genes, pathways and established
risk SNPs associated with LN for each ethnic group. Gene-based analyses showed signifi-
cant associations between variation in ZNF546 (p = 1.0E-06), TRIM15 (p = 1.0E-06), and
TRIMI0 (p = 1.0E-06) and LN among South Europeans, and TTC34 (p = 8.0E-06) was signif-
icantly associated with LN among Hispanics. The SNP rs8091180 in NFATC1 was associ-
ated with LN (OR 1.43, p = 3.3E-04) in the candidate SNP meta-analysis with the highest
OR among African-Americans (OR 2.17, p = 0.0035).
Conclusion
Distinct genetic factors are associated with the risk of LN in SLE patients of different ethnici-
ties. CKD risk alleles may play a role in the development of LN in addition to SLE-associated
risk variants. These findings may further explain the clinical heterogeneity of LN risk and
response to therapy observed between different ethnic groups.
Introduction
Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE) affecting
approximately 40–70% of patients, and contributes substantially to the overall morbidity and
mortality of this disease [1]. Hispanic, African American, and Asian patients develop SLE at a
younger age and more severe manifestations including LN, than patients of European descent
[2]. The etiology of these ethnic disparities is a matter of ongoing debate, with genetic and
non-genetic factors being implicated [3]. Previous work has shown that European ancestry is
protective for LN whereas Amerindian and African ancestry contributes to risk [4, 5]. While
establishing that genetic ancestry is important, studies seeking to define the genetic risk factors
driving LN among SLE patients of different ethnicities have been inconclusive [4]. This might
be due to several factors, such as the risk loci examined were associated with SLE but might
not be relevant to the risk of LN, or the platforms used did not have adequate genome-wide
coverage for the studied ethnic group. Finally, SLE-associated risk loci have mainly been
described in populations of European ancestry, although combined studies of European and
Chinese SLE suggest that the majority of SLE susceptibility loci overlap between these distinct
population groups [6]. The current study aims to better define genetic variants that could
explain the differential risk of LN across ethnic groups.
Genetic variants other than SLE-associated risk alleles may be relevant to the ethnic-specific
risk of LN. Murine models of SLE and LN have indicated that interactions between genes with
different functions contribute to the development of severe LN. These genes include not only
those involved in immune processes, but also genes governing renal function or the handling
of apoptotic debris [1]. Supporting this view, a genome-wide association study (GWAS) of LN
in SLE patients of European descent revealed that the strongest association fell outside of the
MHC region, at a variant located close to PDGFRA, which had not been identified in SLE risk
GWAS [7]. Furthermore a variant in APOL1 has been implicated in the development of early
onset of kidney failure as well as end-stage renal disease in African Americans. This risk vari-
ant has also been associated with LN in patients of African American descent [8]. To better
examine how genetic risk factors for LN may differ between difference ethnic groups, we per-
formed genome-wide SNP genotyping on a well-characterized cohort of lupus patients from 5
ethnic groups: North European, South European, Asian, Hispanic, and African American.
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Individuals of European ancestry were divided into North and South European groups as this
sub-stratification confers distinct risk for particular SLE phenotypes [9, 10]. Our approach
included gene-based association testing utilizing genome-wide data as well as a candidate SNP
analysis of established risk variants for SLE, LN and chronic kidney disease (CKD). We
observed that the genes and pathways most associated with LN differ across ethnicities. Genes
not known to be associated with LN, such as TRIM10, TRIM15, and ZNF456were associated
with LN only among South Europeans, and TTC34was associated with LN among Hispanics.
Furthermore, our candidate SNP analysis revealed several chronic kidney disease (CKD) risk
SNPs associated with LN. Distinct genetic risk factors may influence the risk of LN among eth-
nicities, which could contribute to the difference in prevalence of LN different ethnic groups.
Materials and methods
Participants
Ethics statement. Written informed consent was obtained from all study participants and
the institutional review board at each collaborating center approved the study (institutional
review board of the University of San Francisco California, institutional review board of Okla-
homa Medical Research Foundation, Monash Health Human Research Ethics Committee and
the institutional review board of the University of California Los Angeles).
We studied East Asian, Hispanic, North European, South European, and African American
patients from established lupus cohorts. A total of 1273 SLE cases were obtained from the US
(n = 888), Australia (n = 76), Spain (n = 160), and Mexico (n = 120). All participants fulfilled
the American College of Rheumatology (ACR) revised classification criteria for SLE [11]. Par-
ticipants were grouped according to self-reported ethnicity. All research was approved by an
institutional review board or appropriate ethics committee at each site. Participants were
recruited from a variety of settings, including academic medical centers and community hospi-
tals. Table 1 shows the distribution of these participants by self-reported ethnicity. Our pri-
mary outcome variable was the presence of LN, defined as fulfilling the ACR classification
criteria for renal manifestation of SLE (>0.5 grams of proteinuria per day or 3+ protein on
urine dipstick analysis) or having evidence of LN on kidney biopsy.
Genotyping, imputation and quality assurance
DNA was collected from blood or saliva (Oragene DNA sample collection kits, DNAGenotek)
from all study participants. All participants were genotyped simultaneously using the Affyme-
trix LAT1 World array at the University of California, San Francisco, Institute of Human
Genetics Genomics Core Facility. This high-throughput genotyping array is composed of
Table 1. Clinical Characteristics of the 1,244 participants with systemic lupus erythematosus.
Characteristics North European
n = 255
South European
n = 263
Asian
n = 238
African American
n = 224
Hispanic
n = 264
Female n (%) 224 (87.9) 238 (90.2) 213 (89.5) 212 (94.6) 245 (93.2)
Age of Onset
(mean in years, +/- SD)
36 +/- 14 31 +/- 12 28 +/- 12 33 +/- 13 30 +/- 11
SLE Duration
(mean in years, +/- SD)
9.2 +/- 8 10.6 +/- 9 8.3 +/- 8 8.8 +/- 8 7.1 +/- 7
Lupus Nephritis n (%) 94 (37) 106 (40.5) 146 (61.9) 123 (55.2) 137 (52.1)
Anti dsDNA positive n (%) 130 (50.1) 104 (62.3) 179 (75.2) 148 (66.1) 149 (67.1)
SD = standard Deviation
https://doi.org/10.1371/journal.pone.0199003.t001
Genetics and lupus nephritis
PLOS ONE | https://doi.org/10.1371/journal.pone.0199003 June 28, 2018 3 / 15
817,810 single nucleotide polymorphism (SNP) markers across the genome and was specifi-
cally designed to maximize coverage for diverse ethnic populations, including West Africans,
Europeans and Native Americans [12]. Samples were filtered based on having call rate< 95%,
discrepancies between reported and genetic assessed gender, and evidence of relatedness (one
of each first degree relative pairs removed, defined by identity by descent pi-hat > 0.25). For
evidence of departure from Hardy-Weinberg equilibrium (HWE), we chose to examine LN
negative and dsDNA negative participants among the North European and Asian ethnic
groups. These ethnic groups were the most homogeneous with regards to continental genetic
ancestry. SNPs were removed from analysis if evidence of departure from HWE was present
(p< 5 E-08 in self-identified Europeans and p< 1 E-05 in self-identified Asians) and if geno-
typing call rates were below 95%. Standard Affymetrix Axiom metrics were also applied (DQC
0.82 and default cluster metrics of SNPolisher). After applying these quality control assess-
ments, 1244 participants and 801,067 SNPs remained in analysis. Genotypes of variants that
passed quality control underwent imputation on the University of Michigan Imputation Server
(imputationserver.sph.umich.edu/index.html). Imputation was performed using the 1000
genomes phase 3 reference panels for each ethnic group. Variants with imputation quality
INFO score <0.7 and minor allele frequency<1% were excluded from the analysis [13].
Statistical analysis
Ancestry calculations. Because self-identified ethnicity is an imprecise proxy for the
actual genetic ancestry of an individual, we used SNP data to estimate the overall genetic
ancestry (i.e., % ancestry of the 5 ethnic groups under study) for each participant using the
program ADMIXTURE[14] (S1 Fig). We ran a supervised calculation assuming admixture
with 5 parental populations, utilizing available data from the HapMap project (TSI and Basque
for South Europeans, CEU, AFR, EAS, and PIMA) [15], the Human Genome Diversity Project
[16], and collaborators (M. Seldin, University of California, Davis). From a set of established
ancestry informative markers, 609 autosomal SNPs genotyped on the Affymetrix LAT1 World
array that overlapped with all the reference panels were used to estimate genetic ancestry.
Gene-based tests of association. Initial analyses included gene-based tests of association
with LN. These methods can identify the enrichment of multiple SNPs associated with the dis-
ease/trait when the association for individual SNPs may not reach genome-wide significance
[17]. Genome wide-association testing was done within each ethnic group using logistic
regression modeling with LN status as the outcome, and each SNP as the primary predictor,
adjusting for sex, age, disease duration, and genetic ancestry utilizing PLINK version 1.90 beta
[18]. Gene-based tests of association were performed separately for each ethnic group utilizing
all genes with SNPs that passed quality assurance measures (i.e., a genome-wide assessment).
VEGAS2 [19] was used to assign SNPs to genes (within 50KB, using Human Genome version
19) and produce gene-based test statistics and empirical p values by simulation. Varying pat-
terns of LD were taken into consideration in the gene-based analysis by selecting the most rele-
vant reference population. Pathway analysis under this approach consists of aggregating
association strength of individual markers into pre-specified biological pathways. This method
accounts for gene size and linkage disequilibrium between markers using simulations from the
multivariate normal distribution. Pathway size is taken into account via a resampling approach
[20].
Ethnic-specific candidate SNP analysis. After review of large published GWAS, associa-
tion studies, and meta-analyses, 202 SNPs with replicated associations with SLE, LN and/or
CKD were selected for analysis (S1–S3 Tables). Among these 202 SNPs, 67 were genotyped
and 137 were imputed. Association testing was done within each ethnic group using logistic
Genetics and lupus nephritis
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regression modeling with LN status as the outcome, and each SNP as the primary predictor,
adjusting for sex, age, disease duration, and genetic ancestry utilizing PLINK version 1.90 beta
[18]. Association summary statistics for each candidate gene SNP were combined using meta-
analysis techniques across ethnic groups in PLINK under a random effects model. Heterogene-
ity in allelic effects between ethnic groups at each variant was assessed using Cochran’s Q and
the I-square statistics [21].
Results
Of the 1244 SLE participants, 606 patients had LN (48.7%). This varied significantly according
to ethnicity (Table 1), with the highest rate of LN observed in Asians (61%) and the lowest rate
observed in North Europeans (37%). Genetic admixture was seen in multiple self-identified
ethnic groups and in particular the Hispanic population, where the mean Native American
(NA) ancestry was 46% (S1 Fig). Both North and South European populations had significant
intercontinental admixture between Northern and Southern Europe. The African American
population in this study had a small degree of admixture with 8% mean of North European
ancestry; however, some African American individuals had up to 60% North European
ancestry.
As reported previously, we observed a protective effect of European ancestry with LN across
the 5 ethnicities adjusting for age, sex, and disease duration (Table 2). Although East Asian
and African ancestry were associated with LN, after adjusting for other ancestries, only the
European protective effect (North and South) persisted.
Using gene-based tests of associations within each ethnic group, 4 genes were significantly
associated with LN (p<1.0E-06, Bonferroni threshold, alpha = 2.5x10-6 for 20,000 gene tests)
in 2 ethnic groups (Table 3). Four of the top 5 gene-based associations within each racial/eth-
nic group had p<0.05 in at least one other racial/ethnic group (SYNJ2, MMEL1, FAM213B,
and OR10C1). TRIM10 and TRIM15 encode for 2 members of the superfamily of tripartite
motif-containing (TRIM) proteins. ZNF546 encodes for a transcription factor of the ZNF
Table 2. Association between continental ancestry and lupus nephritis among 1244 SLE patients.
Model  OR (95% CI) for LN given 25% increase in
ancestry
P
Model 1 (NE ancestry, disease duration, sex) 0.84 (0.77–0.92) 0.00016
Model 2 (SE ancestry, disease duration, sex) 0.79 (0.71–0.87) 4.94 E-
06
Model 3 (NA ancestry, disease duration, sex) 1.05 (0.92–1.21) 0.465
Model 4 (EAS ancestry, disease duration, sex) 1.22 (1.12–1.32) 6.11 E-
06
Model 5 (AFR ancestry, disease duration, sex) 1.14 (1.04–1.25) 0.005
Model 6:
NE + other genetic ancestries, disease duration,
sex
0.82 (0.7–0.96) 0.013
SE + other genetic ancestries, disease duration, sex 0.77 (0.65–0.91) 0.003
EAS + other genetic ancestries, disease duration,
sex
1.05 (0.86–1.18) 0.48
AFR + other genetic ancestries, disease duration,
sex
1.01 (0.86–1.27) 0.85
 OR = odds ratio, 95% CI = 95% Confidence Interval
 Adjusted values between parentheses. NE = North European, SE = South European, NA = Native American,
EAS = Asian, AFR = African, LN = lupus nephritis
https://doi.org/10.1371/journal.pone.0199003.t002
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family that has not been associated with autoimmunity or kidney disease. Among the strongest
10 associations with LN among South Europeans, there was enrichment for TRIM protein
coding genes (p = 2.1E-10) such as TRIM26 (p = 2.2E-05), TRIM31 (p = 4E-05) and TRIM40
(p = 6E-05) (S4 Table). Although these genes are at the MHC-I region, the top SNP within
TRIM10 and TRIM15 in the gene based analysis harbors no linkage disequilibrium between
SLE associated SNPs in the HLA-DR region. TTC43, associated in Hispanics, encodes for an
Table 3. Genes with the strongest evidence of association with lupus nephritis within each ethnic group.
NE SE HI AA AS Meta
CHR gene P P P P P P
North European
19 AURKC 6.9E-05 0.66 0.59 0.42 0.80 0.36
19 ZNF805 9.4E-05 0.76 0.52 0.44 0.86 0.22
19 ZNF264 9.9E-05 0.68 0.61 0.63 0.97 0.27
19 ZNF460 0.00016 0.80 0.46 0.63 0.55 0.13
5 SLC36A1 0.00034 0.64 0.82 0.55 0.27 0.07
South European
6 TRIM15 0.17 1.0E-06 0.44 0.92 0.35 0.93
6 TRIM10 0.18 1.0E-06 0.41 0.87 0.41 0.80
19 ZNF546 0.93 1.0E-06 0.67 0.14 0.75 0.61
19 ZNF780B 0.86 1.2E-05 0.66 0.23 0.64 0.39
6 TRIM26 0.15 2.2E-05 0.43 0.90 0.51 0.001
Hispanic
1 TTC34 0.48 0.173 8E-06 0.55 0.07 0.49
6 NRM 0.55 0.548 1.2E-05 0.65 0.60 0.002
1 MMEL1 0.72 0.037 3E-05 0.58 0.07 0.64
6 PPP1R18 0.55 0.492 3.7E-05 0.68 0.54 0.005
1 FAM213B 0.68 0.037 4.3E-05 0.57 0.06 0.001
African American
6 SYNJ2 0.01 0.490 0.36 2.1E-05 0.43 0.60
6 SERAC1 0.30 0.753 0.62 2.7E-05 0.67 0.92
17 UNC13D 0.07 0.134 0.81 0.00010 0.22 0.93
6 OR2H1 0.23 0.080 0.28 0.00013 0.55 0.009
6 OR10C1 0.28 0.006 0.22 0.00016 0.59 0.001
Asian
8 NSMCE2 0.47 0.90 0.44 0.21 0.00022 0.86
10 FANK1 0.74 0.37 0.47 0.63 0.00057 0.95
2 ICOS 0.84 0.62 0.19 0.69 0.00063 0.66
1 FAM151A 0.39 0.01 0.78 0.21 0.00064 0.29
20 DEFB126 0.38 0.64 0.10 0.40 0.00094 0.67
Meta-Analysis
18 LOC400644 0.13 0.09 0.20 0.31 0.03 0.0002
2 LOC101929753 0.006 0.19 0.10 0.73 0.56 0.0003
13 SLC25A15 0.06 0.19 0.01 0.14 0.11 0.0007
22 TUBA3FP 0.07 0.61 0.58 0.61 0.81 0.0012
3 SPICE1 0.46 0.65 0.47 0.07 0.09 0.0022
NE = North European SE = South European HI = Hispanic AA = African American AS = Asian Meta = Meta-analysis
https://doi.org/10.1371/journal.pone.0199003.t003
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uncharacterized protein that has recently been implicated by computational approaches as a
potential auto-antigen in SLE [22].
Pathway analyses utilizing genome-wide data did not reveal statistically significant results
(p< 1 E-05)[19]. The most associated pathways for each ethnic group were different; these
pathway analyses identified top associations at dysregulated immune signaling and fibrotic
responses in the pathogenesis of LN (Table 4). The top network in North Europeans was
receptor-regulated SMAD binding (p = 0.0002). SMADs activate transcription of TGF-β target
Table 4. Pathways with the strongest evidence of association with lupus nephritis within each ethnic group.
Pathway NE SE HI AA AS Meta
Accession P P P P P P
North European
M13070 R-SMAD binding 0.0002 0.62 0.30 0.78 0.92 0.15
M562 Facilitative Na+-independent glucose transporters 0.0004 0.08 0.84 0.38 0.67 0.67
M1012 Hexose transmembrane transporter activity 0.0008 0.36 0.67 0.14 0.08 0.47
GO:0005355 Glucose transmembrane transporter activity 0.0009 0.26 0.69 0.15 0.09 0.40
GO:0031056 Regulation of histone modification 0.0012 0.66 0.60 0.24 0.27 0.12
South European
GO:0070412 Hormone ligand-binding receptors 0.61 0.0003 0.54 0.73 0.05 0.02
M8472 GRB2 events in ERBB2 signaling 0.72 0.001 0.93 0.63 0.79 0.40
GO:0015149 Interleukin-2 signaling 0.92 0.001 0.52 0.74 0.96 0.72
M1718 IL4 receptor signaling in B lymphocytes 0.54 0.002 0.81 0.79 0.84 0.50
RHSA74751 Insulin receptor signaling cascade 0.97 0.002 0.96 0.56 0.38 0.19
Hispanic
M13618 CD28 dependent Vav1 pathway 0.19 0.29 0.0007 0.80 0.24 0.08
PID M54 IL12-mediated signaling events 0.49 0.35 0.0014 0.35 0.73 0.35
PID M84 ATM pathway 0.61 0.71 0.0014 0.97 0.95 0.48
RHSA428540 Activation of RAC1 0.23 0.42 0.0014 0.89 0.25 0.32
GO:0016254 Preassembly of GPI anchor in ER membrane 0.37 0.72 0.0019 0.84 0.28 0.97
African American
GO:0003677 DNA binding 0.44 0.81 0.74 0.0024 0.35 0.46
P02772 Pyruvate metabolism 0.85 0.06 0.92 0.0046 0.14 0.28
GO:0000315 Organellar large ribosomal subunit 0.85 0.06 0.92 0.0046 0.14 0.28
M5940 Endocytotic role of NDK, phosphins and dynamin 0.17 0.81 0.83 0.0047 0.47 0.35
GO:0006109 Regulation of carbohydrate metabolic process 0.75 0.92 0.25 0.0071 0.76 0.82
Asian
M76 p38 signaling mediated by MAPKAP kinases 0.92 0.57 0.40 0.87 0.0007 0.10
M16563 mTOR signaling pathway 0.74 0.28 0.99 0.42 0.0022 0.33
NetPath ID signaling pathway 0.05 0.84 0.45 0.63 0.0043 0.27
M229 Signaling mediated by P38-alpha and P38-beta 0.82 0.14 0.43 0.71 0.0023 0.08
GO:0008191 Metalloendopeptidase inhibitor activity 0.87 0.85 0.30 0.51 0.0055 0.92
Meta-analysis
GO:0005031 TNF-activated receptor activity 0.85 0.04 0.003 0.47 0.31 0.0027
GO:0005035 Death receptor activity 0.82 0.05 0.007 0.62 0.41 0.0040
GO:0043120 TNF binding 0.87 0.05 0.005 0.51 0.41 0.0046
GO:0005072 TGF B receptor cytoplasmic mediator activity 0.03 0.07 0.56 0.31 0.96 0.0061
GO:0005071 Serine/threonine kinase signaling protein activity 0.05 0.07 0.66 0.24 0.95 0.0091
NE = North European SE = South European HI = Hispanic AA = African American AS = Asian Meta = Meta-analysis
https://doi.org/10.1371/journal.pone.0199003.t004
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genes. In Hispanics, the top network implicated was the CD28 dependent Vav1 signaling path-
way (p = 0.0007). The second top network in Hispanics was related to 1L-12 mediated signal-
ing events (p = 0.0014). In Asians, the top networks included the p38MAPK pathway,
(p = 0.0007), the mTOR signaling pathway (p = 0.0022) and the family of inhibitor of differen-
tiation (ID) proteins (p = 0.0023). Finally, in the meta-analysis, TNF-related pathways showed
the strongest evidence of association.
Candidate SNP analysis
Table 5 shows the most significantly associated SNPs within each ethnicity in comparison to
the other ethnic groups. The associations between candidate SNPs and LN did not reach statis-
tical significance in any specific ethnic group. However, the most significantly associated SNPs
for each ethnic group are largely distinct, with only one SNP overlapping between 2 ethnic
groups (rs3184504 in SH2B3 for both North and South Europeans). Of note, many of these top
SNPs are risk alleles for CKD and not SLE, such as ETV4 and GCKR in Hispanics, NFATC1
and SYPL2 in African Americans, DAB2 and KBTBD2 in Asians, and PRKAG2 in South
Europeans.
To investigate whether different genetic variants contribute to LN susceptibility across dif-
ferent ethnic groups, we constructed a genetic risk score (GRS), comprised of candidate SNPs
with p<0.05 for association with LN. The GRS was calculated for each individual by summing
number of risk alleles for each SNP in the GRS. The GRS was not predictive of LN when look-
ing across all individuals, or when looking within ethnic groups (data not shown). We then
constructed a ethnic-specific GRS, comprised of candidate SNPs with p<0.05 for association
with LN in that ethnic group. The distribution of the 5 ethnic-specific GRS was significantly
different across groups (ANOVA, p<0.0007), which supports the hypothesis. Only the GRS
calculated from the top North European SNPs was a significant predictor of LN (p = 0.0001 in
NE, p = 0.03 in other populations combined) (S5 Table). In the candidate SNP analysis,
rs8091180 in NFATC1 was most highly associated with LN across ethnic groups (trans-ethnic
meta-analysis OR 1.43, p = 0.0003). The effect was stronger in the African Americans, with an
OR of 2.17 (p = 0.00357). We utilized the genome-wide data available to examine the region.
When looking at the entire cohort, this SNP remained the strongest signal in the region (Fig
1A). However, when examining the region among African Americans, the imputed SNP
rs68734 appeared to be more strongly associated (p-value = 1.06E−4) (Fig 1B).
As observed in the meta-analysis (Table 5), 13 out of 25 of the most significantly associated
SNPs had an I2 of greater that 50% suggesting heterogeneity. We examined whether the associ-
ation of these previously established risk alleles was different among the ethnic groups. Several
SNPs had a p-value for the Q statistic approaching statistical significance of 0.0005 after adjust-
ing for multiple comparisons. The most extreme differences between population pairs were
between Asians and South Europeans for rs11959928 in DAB2 (Q = 0.0005, I2 = 91.63) and
between North and South Europeans for rs7805747 in PRKAG2 (Q = 0.0006, I2 of 91.5). In
both scenarios, the effect estimates of the minor alleles were in different directions (risk versus
protective).
Discussion
This study aimed to identify genetic variants contributing to the differential risk of LN among
SLE patients of different ethnicities. Overall, in gene-based, pathway, and candidate SNP anal-
yses, we found that the genetic associations differed between ethnic groups. We found novel
associations with 4 genes as well as distinct biological pathways associated with LN in particu-
lar ethnic groups. We also found evidence of a potential association of SNP rs8091180 in the
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NFATC1 gene with lupus nephritis, which was strongest in for African-Americans and has not
been previously associated with LN or SLE. Finally, the results of our study highlight the
importance of CKD risk loci over SLE risk loci for the development of nephritis in SLE.
Using a genome-wide gene-based approach, we saw an enrichment of members of the
TRIM family genes associated with LN only among South Europeans. The TRIM proteins
have important roles in innate immunity and antiviral response, in particular in retroviral
restriction and antiviral defense [23]. This is consistent with the well-established interferon
Fig 1. Locus plots of association of SNPs in the NFATC1 region with renal disease. (A) All SLE participants. (B)
African-American participants.
https://doi.org/10.1371/journal.pone.0199003.g001
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(IFN) response in SLE, as well as newer evidence implicating activation of retroviral elements
as potential triggers of SLE [24, 25]. The function of TRIM10 remains unknown. TRIM15 has
been found to be up-regulated in human THP1-derived macrophages after activation with
TLR3 ligands [26]. TLR3 recognizes double-stranded RNA (the genetic basis of retroviruses)
and upon recognition, it induces the activation of IRF3 to increase production of type I IFNs.
This is suggestive of linking a potential variant influencing the function of at least TRIM15,
which would have an effect on the ability to restrict endogenous retro-elements from inducing
an IFN response. If confirmed in independent datasets, additional work will be required to
understand why these genes are associated with LN only among South Europeans, although
differences in selection pressures in different geographic regions might explain such differ-
ences [27]. Due to the nature of the gene-based analysis, we do not have the direction of the
association (protective or risk), but we know that Europeans are protected from LN in com-
parison to other populations [4].
In Hispanics, TTC34was associated with LN. This gene is significantly enriched with simple
tandem repeat (STR) sequences, conferring vulnerability to somatic mutation. It was recently
described as a potential autoantigen, in particular in SLE [28]. We are not aware of previous
reports of anti-TTC34 antibodies in serum of SLE patients.
LN continues to be a therapeutic challenge, and there continues to be a great need for more
effective treatments. Even with advances in care, the 10-year cumulative incidence of ESRD is
10.1% and of death is 5.9% [29]. Understanding the complex heterogeneity of LN is key to
developing more targeted treatments. Treatment response in LN also differs between ethnici-
ties [29]. Although these findings will need to be replicated in other cohorts, it is of interest
that the pathways with the strongest evidence of association were biologically relevant to renal
disease and differed across ethnicities. These findings could inform future treatment strategies.
For example, in Asians, one of the top pathways included the mTOR signaling pathway, which
has been implicated in both SLE and LN pathogenesis [30, 31]. Another interesting pathway in
this particular group is the family of inhibitor of differentiation (ID) proteins, which have been
shown to play a role in steering multipotent progenitors away from the lymphoid lineages,
thus allowing them to differentiate into myeloid and dendritic cells [32]. Targeting the SMAD/
TGF pathway, the top pathway associated in North Europeans, might be an effective strategy
for this group. TGFβ-SMAD signaling has a central role in kidney fibrosis and progression to
CKD, which has led to SMADs being recently identified as therapeutic targets for CKD [33,
34].
When examining previously established candidate risk SNPs, we observed the same pattern:
the SNPs with the strongest evidence of association differed in each ethnic group. In addition,
there was an association of SNP rs809180 in NFATC1 with LN across ethnicities. NFATC1 is a
validated CKD risk loci and encodes for nuclear factor of activated T-cells (calcineurin depen-
dent 1) that is involved in the activation of the T-cell antigen receptor [35, 36]. We sought to
replicate this finding in an independent cohort of 1620 African American lupus patients, as we
observed the strongest association with LN among this group. Sixty-six SNPs in the NFATC1
region were examined for association with lupus nephritis. Although rs8091108 did not repli-
cate, [OR 1.02 95%CI 0.85–1.23, p = 0.8] two other SNPs within this gene where associated
with LN, rs11660906 (OR 0.45 95% CI 0.27–0.74, p = 0.0013,) and rs11663132 (OR 0.46 95%
CI 0.28–0.76, p = 0.0018), indicating that variants in this region may be associated with LN.
NFATC1 is targeted by cyclosporine and tacrolimus, which have been used to prevent renal
transplant rejection and treat some cases of LN [37]. Furthermore, NFATC1 has been recently
described as an important regulator of cytotoxic T lymphocyte effector functions [35]. Experi-
mental studies showed that a loss-of-function mutation in the ancestral orthologue of
NFATC1 in Drosophila melanogaster was associated with altered sensitivity to salt stress,
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suggesting a role for this gene in ionic or osmotic regulation [38]. Endogenous signals, such as
interstitial osmolality, may influence the immune kidney landscape. Increased extracellular
sodium skews CD4 T cells to a Th17 phenotype [39, 40] and kidney medullary hypersalinity
has shown to cause NFAT5-dependent recruitment of circulating monocyte-derived mononu-
clear phagocytes into the region [41]. Therefore, a high salt intake coupled with a genetic pre-
disposition to salt sensitivity might contribute to renal disease in SLE patients.
A major strength of our study is the incorporation of multiple ethnic groups and their
assessment using the same genotyping platform. This design allowed for the simultaneous
examination of predisposing loci for renal disease among all study participants. Our candidate
SNP analysis incorporated risk loci not only for SLE, but also LN and CKD. A recognized limi-
tation of our study is the relatively small sample size within each ethnic group, which limited
our statistical power for ethnic-specific analyses. Another limitation is that our candidate SNP
study was limited to SNPs that primarily have been identified and validated in populations of
European descent. In support of this bias, the GRS was only significantly associated with LN in
North Europeans. Therefore, we cannot exclude the presence of one or more potentially func-
tional variants (common or rare) in loci not identified in the current study.
Conclusions
In summary, we provide evidence of ethnic-specific genetic factors influencing the risk of LN
among SLE patients, with corroboration of our findings (e.g., the association of TRIM10 and
TRIM15 in South Europeans) needed in future studies. While fine mapping is needed to pin-
point causal variation in relevant populations, this study represents progress in elucidating the
genetic underpinnings driving LN among SLE patients of different ethnicities.
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